Skip to main content

Advertisement

Log in

Immunocytochemical detection of p21ras expression in fresh human leukaemic cells and cell lines

  • Short Communication
  • Published:
Blut Aims and scope Submit manuscript

Summary

The expression of p21 rasproteins was investigated by immunocytochemistry in permanent cell lines and in fresh human leukaemic cells. While high and low levels of p21 rascould be detected in most of the cell lines, no significant p21 rasimmunoreactivity was noted in cells of ten human acute and chronic leukaemias. Thus, notwithstanding its possible role in the initial transformation process in human leukaemias, p21 rasexpression appears not to be an irrevocable requirement for the maintenance of the transformed state.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Andreeff M, Slater DE, Bressler J, Furth ME (1986) Cellular ras oncogene expression and cell cycle measured by flow cytometry in hematopoietic cell lines. Blood 67: 676–681

    Google Scholar 

  2. Barbacid M (1987) ras Genes. Ann Rev Biochem 56: 779–827

    Google Scholar 

  3. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293–297

    Google Scholar 

  4. Bos JL, Verlaan-de Vries M, van der Eb AJ, Janssen JWG, Delwel R, Löwenberg B, Colly LP (1987) Mutations in N-ras predominate in acute myeloid leukemia Blood 69: 1237–1241

    Google Scholar 

  5. Chesa PG, Rettig WJ, Melamed MR, Old LJ, Niman HL (1987) Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy. Proc Natl Acad Sci USA 84: 3234–3238

    Google Scholar 

  6. Cohen JB, Levinson AD (1988) A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature 334: 119–124

    Google Scholar 

  7. Cordell JL, Falini B, Erber WN, Ghosh Ak, Abdulaziz Z, Macdonald St, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219–229

    Google Scholar 

  8. Gallick GE, Kurzrock R, Kloetzer WS, Arlinghaus RB, Gutterman JU (1985) Expression of p21ras in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci USA 82: 1795–1799

    Google Scholar 

  9. Hirai H, Kobayashi Y, Mano H, Maru Y, Omine M, Mizoguchi H, Nishida J, Takaku F (1987) A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndromes. Nature 327: 430–432

    Google Scholar 

  10. Liu E, Hjelle B, Morgan R, Hecht F, Bishop JM (1987) Mutations of the Kirsten-ras proto-oncogene in human preleukemia. Nature 330: 186–188

    Google Scholar 

  11. Lyons J, Janssen JWG, Bartram C, Layton M, Mufti GJ (1988) Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. Blood 71: 1707–1712

    Google Scholar 

  12. Shen WPV, Aldrich TH, Venta-Perez G, Franza BR, Furth ME (1987) Expression of normal and mutant ras proteins in human acute leukemia. Oncogene 1: 157–165

    Google Scholar 

  13. Studzinski GP, Brelvi ZS (1987) Increased expression of oncogene c-Ha-ras during granulocytic differentiation of HL60 cells. Lab Invest 56: 499–504

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neubauer, A., Herbst, H., Rochlitz, C. et al. Immunocytochemical detection of p21ras expression in fresh human leukaemic cells and cell lines. Blut 59, 460–463 (1989). https://doi.org/10.1007/BF00349069

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00349069

Key words

Navigation